Vitrafy Life Sciences Limited (ASX:VFY)
Australia · Delayed Price · Currency is AUD 3.690
+0.070 (1.93%)
Oct 6, 2026, 12:00 PM AEST
Vitrafy Life Sciences Market Cap
Vitrafy Life Sciences has a market cap or net worth of 275.84 million as of October 5, 2026. Its market cap has increased by 220.01% in one year.
Market Cap
275.84M
Enterprise Value
234.92M
Revenue
209.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
3.69
ChartMarket Cap Chart
Since November 26, 2024, Vitrafy Life Sciences's market cap has increased from 126.42M to 275.84M, an increase of 118.19%. That is a compound annual growth rate of 52.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 275.84M | 237.51% |
| Dec 30, 2025 | 81.73M | -24.71% |
| Dec 31, 2024 | 108.54M | -14.14% |
| Nov 26, 2024 | 126.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cuscal | 1.26B |
| Aura Consolidated Group | 805.91M |
| FINEOS Corporation Holdings | 690.08M |
| Tyro Payments | 362.45M |
| Acusensus | 176.44M |
| Wrkr Ltd | 157.79M |
| Decidr AI Industries | 105.75M |
| EML Payments | 94.45M |